Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2013 07:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome From French Research Institutes

Raptor Expands its Cysteamine Rights for the Treatment of Neurologic Disorders License Grants Raptor Exclusive Worldwide Rights to the Use of Cysteamine and Related Compounds in the Treatment of...
March 14, 2013 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Reports Financial Results for the Transition Period From September 1, 2012 to December 31, 2012

NOVATO, Calif., March 14, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today reported financial results for its four month transition period from...
February 26, 2013 17:15 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the Cowen and Company 33rd Annual Health Care Conference

NOVATO, Calif., Feb. 26, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), today announced that Julie Anne Smith, executive vice president, strategy and chief operating officer of...
February 05, 2013 16:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at Upcoming Investor Conferences

NOVATO, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), today announced that the company's management will present at two upcoming investor conferences in February....
January 09, 2013 16:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Reports First Quarter Fiscal Year 2013 Financial Results

NOVATO, Calif., Jan. 9, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today reported financial results for its first fiscal quarter ended November 30,...
December 21, 2012 16:29 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Provides Update on PROCYSBI(TM) NDA Review

NOVATO, Calif., Dec. 21, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that the U.S. Food and Drug Administration ("FDA") will require...
December 20, 2012 09:00 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Signs $50 Million Loan Agreement With HealthCare Royalty Partners

NOVATO, Calif., Dec. 20, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that it has signed a $50 million loan agreement with HealthCare...
November 14, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Reports Fourth Quarter and Fiscal Year 2012 Financial Results

NOVATO, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today reported financial results for its fourth quarter and fiscal year ended...
November 09, 2012 14:10 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference 2012

NOVATO, Calif., Nov. 9, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Julie Anne Smith, Executive Vice President, Strategy and...
November 05, 2012 06:30 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Corp. Announces Positive Data on RP103 Extension Study Presented at Kidney Week 2012

NOVATO, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), announced that Craig B. Langman, M.D., Head of Kidney Diseases, and the Isaac A....